| __timestamp | Exelixis, Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 189101000 | 242549000 |
| Thursday, January 1, 2015 | 96351000 | 245098000 |
| Friday, January 1, 2016 | 95967000 | 147600000 |
| Sunday, January 1, 2017 | 112171000 | 264600000 |
| Monday, January 1, 2018 | 182257000 | 357900000 |
| Tuesday, January 1, 2019 | 336964000 | 1182600000 |
| Wednesday, January 1, 2020 | 547851000 | 357700000 |
| Friday, January 1, 2021 | 693716000 | 540100000 |
| Saturday, January 1, 2022 | 891813000 | 322900000 |
| Sunday, January 1, 2023 | 1044071000 | 408000000 |
| Monday, January 1, 2024 | 910408000 |
Cracking the code
In the competitive world of biotechnology, strategic investments in research and development (R&D) are crucial for innovation and growth. Over the past decade, United Therapeutics Corporation and Exelixis, Inc. have demonstrated contrasting approaches to R&D spending. From 2014 to 2023, Exelixis, Inc. increased its R&D expenses by over 450%, peaking in 2023 with a 1.04 billion dollar investment. This aggressive strategy underscores Exelixis's commitment to expanding its drug pipeline and enhancing its market position. Meanwhile, United Therapeutics Corporation maintained a more stable R&D expenditure, with a notable spike in 2019, reaching 1.18 billion dollars. This reflects a balanced approach, focusing on sustainable growth and strategic innovation. As these companies continue to navigate the evolving biotech landscape, their R&D strategies will play a pivotal role in shaping their future success.
Analyzing R&D Budgets: Sanofi vs United Therapeutics Corporation
Gilead Sciences, Inc. or United Therapeutics Corporation: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Vertex Pharmaceuticals Incorporated vs United Therapeutics Corporation
Regeneron Pharmaceuticals, Inc. or United Therapeutics Corporation: Who Invests More in Innovation?
Research and Development Expenses Breakdown: United Therapeutics Corporation vs Apellis Pharmaceuticals, Inc.
Analyzing R&D Budgets: United Therapeutics Corporation vs MorphoSys AG
United Therapeutics Corporation or Vericel Corporation: Who Invests More in Innovation?
United Therapeutics Corporation or Ligand Pharmaceuticals Incorporated: Who Invests More in Innovation?
Exelixis, Inc. or TG Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Exelixis, Inc. and Ultragenyx Pharmaceutical Inc.
Analyzing R&D Budgets: Exelixis, Inc. vs Veracyte, Inc.
Exelixis, Inc. or Mesoblast Limited: Who Invests More in Innovation?